AIM: The optimal initial fraction of oxygen (iFiO2 ) for resuscitating/stabilising premature infants is not known. We aimed to study currently available information and provide guidelines regarding the iFiO2 levels needed to resuscitate/stabilise premature infants of ≤32 weeks' gestation. METHODS: Our systematic review and meta-analysis studied the effects of low and high iFiO2 during the resuscitation/stabilisation of 677 newborn babies ≤32 weeks' gestation. RESULTS: Ten randomised studies were identified covering 321 infants receiving low (0.21-0.30) iFiO2 levels and 356 receiving high (0.60-1.0) levels. Relative risk for mortality was 0.62 (95% CI: 0.37-1.04, I(2) = 0%, p(heterogeneity) = 0.88) for low versus high iFiO2 ; for bronchopulmonary dysplasia, it was 1.11 (95% CI: 0.73-1.68, I(2) = 46%, p(heterogeneity) = 0.06); and for intraventricular haemorrhage, it was 0.90 (95% CI: 0.53-1.53, I(2) = 9%, p(heterogeneity) = 0.36). CONCLUSION: These data show that reduced mortality approached significance when a low iFiO2 (0.21-0.30) was used for initial stabilisation, compared to a high iFiO2 (0.60-1.0). There was no significant association for bronchopulmonary dysplasia or intraventricular haemorrhage when comparing low and high iFiO2 . Based on present data, premature babies ≤32 weeks' gestation in need of stabilisation in the delivery room should be given an iFiO2 of 0.21-0.30.
AIM: The optimal initial fraction of oxygen (iFiO2 ) for resuscitating/stabilising premature infants is not known. We aimed to study currently available information and provide guidelines regarding the iFiO2 levels needed to resuscitate/stabilise premature infants of ≤32 weeks' gestation. METHODS: Our systematic review and meta-analysis studied the effects of low and high iFiO2 during the resuscitation/stabilisation of 677 newborn babies ≤32 weeks' gestation. RESULTS: Ten randomised studies were identified covering 321 infants receiving low (0.21-0.30) iFiO2 levels and 356 receiving high (0.60-1.0) levels. Relative risk for mortality was 0.62 (95% CI: 0.37-1.04, I(2) = 0%, p(heterogeneity) = 0.88) for low versus high iFiO2 ; for bronchopulmonary dysplasia, it was 1.11 (95% CI: 0.73-1.68, I(2) = 46%, p(heterogeneity) = 0.06); and for intraventricular haemorrhage, it was 0.90 (95% CI: 0.53-1.53, I(2) = 9%, p(heterogeneity) = 0.36). CONCLUSION: These data show that reduced mortality approached significance when a low iFiO2 (0.21-0.30) was used for initial stabilisation, compared to a high iFiO2 (0.60-1.0). There was no significant association for bronchopulmonary dysplasia or intraventricular haemorrhage when comparing low and high iFiO2 . Based on present data, premature babies ≤32 weeks' gestation in need of stabilisation in the delivery room should be given an iFiO2 of 0.21-0.30.
Authors: Jesus Prieto-Lloret; Maria Ramirez; Elena Olea; Javier Moral-Sanz; Angel Cogolludo; Javier Castañeda; Sara Yubero; Teresa Agapito; Angela Gomez-Niño; Asuncion Rocher; Ricardo Rigual; Ana Obeso; Francisco Perez-Vizcaino; Constancio González Journal: J Physiol Date: 2015-05-15 Impact factor: 5.182
Authors: Julia Kuligowski; Marta Aguar; Denise Rook; Isabel Lliso; Isabel Torres-Cuevas; Javier Escobar; Guillermo Quintás; María Brugada; Ángel Sánchez-Illana; Johannes B van Goudoever; Máximo Vento Journal: Antioxid Redox Signal Date: 2015-04-13 Impact factor: 8.401
Authors: Matthias C Hütten; Tom G Goos; Daan Ophelders; Maria Nikiforou; Elke Kuypers; Monique Willems; Hendrik J Niemarkt; Jenny Dankelman; Peter Andriessen; Thilo Mohns; Irwin K M Reiss; Boris W Kramer Journal: Pediatr Res Date: 2015-08-31 Impact factor: 3.756
Authors: E Sabrina Twilhaar; Rebecca M Wade; Jorrit F de Kieviet; Johannes B van Goudoever; Ruurd M van Elburg; Jaap Oosterlaan Journal: JAMA Pediatr Date: 2018-04-01 Impact factor: 16.193